JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266083

Human MTCH2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MTCH2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human MTCH2 knockout HEK-293T cell line (AB266083)
  • Sanger seq

Unknown

Sanger Sequencing - Human MTCH2 knockout HEK-293T cell line (AB266083)

Homozygous : 1 bp insertion in exon1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266083-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266083 Human MTCH2 knockout HEK-293T cell line", "number":"AB266083-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266083-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266083-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266083-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266083 Human MTCH2 knockout HEK-293T cell line", "number":"AB266083-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266083-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266083 Human MTCH2 knockout HEK-293T cell line", "number":"AB266083-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266083-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266083 Human MTCH2 knockout HEK-293T cell line", "number":"AB266083-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MTCH2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MTCH2 also known as Mitochondrial Carrier Homolog 2 serves as a protein involved in mitochondrial function. It has a mass of approximately 33 kDa. This protein sees high levels of expression in adipose tissue liver heart and skeletal muscle indicating its role in energy metabolism and homeostasis. MTCH2 localizes to the outer mitochondrial membrane where it impacts the transfer of metabolic substrates and signals across the mitochondrial barrier.
Biological function summary

MTCH2 plays a significant role in regulating mitochondrial apoptosis and metabolism. It is involved in the control of lipid and glucose metabolism essential for maintaining cellular energy balance. MTCH2 forms part of a larger protein complex associated with the mitochondrial outer membrane and interacts with several key regulators of apoptosis including tBID. Its function is important to maintaining cell survival and regulating programmed cell death in response to metabolic stress.

Pathways

The regulatory role of MTCH2 integrates it into the mitochondrial apoptosis and lipid metabolism pathways. MTCH2 acts synergistically within the apoptosis pathway by influencing the activity of proteins such as Bax. In the lipid metabolism pathway MTCH2 coordinates with proteins like CD36 to regulate fatty acid uptake and oxidation connecting cellular energy demands with supply.

MTCH2 has relevance to metabolic conditions and neurodegenerative diseases. In obesity alterations in MTCH2 function affect energy metabolism and fat accumulation. In Alzheimer's disease MTCH2 interaction with amyloid precursor protein regulates mitochondrial function and could contribute to neuronal death. MTCH2 associating with tBID and Bax further implicates its role in the progression of these conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com